CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Revenues:
Total revenues	$ 10,524	$ 15,202	$ 31,685	$ 31,990
Operating expenses:
Cost of sales	736	1,202	2,896	3,634
Research and development	29,542	17,363	89,554	46,711
Sales and marketing	24	479	80	11,504
General and administrative	12,970	10,556	39,770	28,854
Total operating expenses	43,272	29,600	132,300	90,703
Loss from operations	(32,748)	(14,398)	(100,615)	(58,713)
Other (expense) income:
Interest and other income, net	3,387	1,786	11,144	4,611
Interest expense	0	0	0	(1,247)
Loss on extinguishment of debt	0	0	0	(1,347)
Total other income, net	3,387	1,786	11,144	2,017
Net loss	$ (29,361)	$ (12,612)	$ (89,471)	$ (56,696)
Net loss per share - basic	$ (0.54)	$ (0.33)	$ (1.67)	$ (1.5)
Net loss per share - diluted	$ (0.54)	$ (0.33)	$ (1.67)	$ (1.5)
Weighted average common shares outstanding - basic	54,449	38,341	53,526	37,804
Weighted average common shares outstanding - diluted	54,449	38,341	53,526	37,804
Net Income (Loss)	$ (29,361)	$ (12,612)	$ (89,471)	$ (56,696)
Other comprehensive gain (loss):
Unrealized gain (loss) on available-for-sale securities	379	(1)	307	55
Comprehensive loss	(28,982)	(12,613)	(89,164)	(56,641)
Product [Member]
Revenues:
Total revenues	664	816	2,390	13,483
License and Collaboration Agreements [Member]
Revenues:
Total revenues	9,561	14,137	27,906	17,768
Royalty Income [Member]
Revenues:
Total revenues	$ 299	$ 249	$ 1,389	$ 739